These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9673556)
1. Hepatic steatosis in liver transplant donors: common feature of donor population? Garcia Ureña MA; Colina Ruiz-Delgado F; Moreno González E; Jiménez Romero C; García García I; Loinzaz Segurola C; Gonzalez-Pinto ; Gómez Sanz R World J Surg; 1998 Aug; 22(8):837-44. PubMed ID: 9673556 [TBL] [Abstract][Full Text] [Related]
2. Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population? Hałoń A; Patrzałek D; Rabczyński J Transplant Proc; 2006; 38(1):193-5. PubMed ID: 16504700 [TBL] [Abstract][Full Text] [Related]
3. An approach to the rational use of steatotic donor livers in liver transplantation. Urena MA; Moreno Gonzalez E; Romero CJ; Ruiz-Delgado FC; Moreno Sanz C Hepatogastroenterology; 1999; 46(26):1164-73. PubMed ID: 10370686 [TBL] [Abstract][Full Text] [Related]
4. Oil Red O Is a Useful Tool to Assess Donor Liver Steatosis on Frozen Sections During Transplantation. Riva G; Villanova M; Cima L; Ghimenton C; Bronzoni C; Colombari R; Crestani M; Sina S; Brunelli M; D'Errico A; Montin U; Novelli L; Eccher A Transplant Proc; 2018 Dec; 50(10):3539-3543. PubMed ID: 30577233 [TBL] [Abstract][Full Text] [Related]
5. Use of severely steatotic grafts in liver transplantation: a matched case-control study. McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095 [TBL] [Abstract][Full Text] [Related]
6. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival. Frongillo F; Avolio AW; Nure E; Mulè A; Pepe G; Magalini SC; Agnes S Transplant Proc; 2009 May; 41(4):1268-72. PubMed ID: 19460535 [TBL] [Abstract][Full Text] [Related]
7. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation. Sharkey FE; Lytvak I; Prihoda TJ; Speeg KV; Washburn WK; Halff GA Hum Pathol; 2011 Sep; 42(9):1337-42. PubMed ID: 21420717 [TBL] [Abstract][Full Text] [Related]
8. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study. Gabrielli M; Moisan F; Vidal M; Duarte I; Jiménez M; Izquierdo G; Domínguez P; Méndez J; Soza A; Benitez C; Pérez R; Arrese M; Guerra J; Jarufe N; Martínez J Ann Hepatol; 2012; 11(6):891-8. PubMed ID: 23109453 [TBL] [Abstract][Full Text] [Related]
9. Use of livers with microvesicular fat safely expands the donor pool. Fishbein TM; Fiel MI; Emre S; Cubukcu O; Guy SR; Schwartz ME; Miller CM; Sheiner PA Transplantation; 1997 Jul; 64(2):248-51. PubMed ID: 9256182 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Fiorentino M; Vasuri F; Ravaioli M; Ridolfi L; Grigioni WF; Pinna AD; D'Errico-Grigioni A Liver Transpl; 2009 Dec; 15(12):1821-5. PubMed ID: 19938115 [TBL] [Abstract][Full Text] [Related]
11. Frozen section diagnosis in donor liver biopsies: observer variation of semiquantitative and quantitative steatosis assessment. Biesterfeld S; Knapp J; Bittinger F; Götte H; Schramm M; Otto G Virchows Arch; 2012 Aug; 461(2):177-83. PubMed ID: 22772768 [TBL] [Abstract][Full Text] [Related]
12. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794 [TBL] [Abstract][Full Text] [Related]
14. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short. Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740 [TBL] [Abstract][Full Text] [Related]
15. Expanding postmortem donor pool using steatotic liver grafts: a new look. Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197 [TBL] [Abstract][Full Text] [Related]
16. Deep learning quantification of percent steatosis in donor liver biopsy frozen sections. Sun L; Marsh JN; Matlock MK; Chen L; Gaut JP; Brunt EM; Swamidass SJ; Liu TC EBioMedicine; 2020 Oct; 60():103029. PubMed ID: 32980688 [TBL] [Abstract][Full Text] [Related]
17. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. Chavin KD; Taber DJ; Norcross M; Pilch NA; Crego H; McGillicuddy JW; Bratton CF; Lin A; Baliga PK Clin Transplant; 2013; 27(5):732-41. PubMed ID: 23991646 [TBL] [Abstract][Full Text] [Related]
18. Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation. Jun MJ; Shim JH; Kim SY; Seo N; Kim KM; Lim YS; Lee HC; Yu E; Lee SG Liver Transpl; 2014 Apr; 20(4):437-45. PubMed ID: 24478019 [TBL] [Abstract][Full Text] [Related]
19. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers. Yersiz H; Lee C; Kaldas FM; Hong JC; Rana A; Schnickel GT; Wertheim JA; Zarrinpar A; Agopian VG; Gornbein J; Naini BV; Lassman CR; Busuttil RW; Petrowsky H Liver Transpl; 2013 Apr; 19(4):437-49. PubMed ID: 23408461 [TBL] [Abstract][Full Text] [Related]
20. A clinopathologic review of 8 liver graft primary nonfunctions. Colina F; Lopez-Carreira M; Moreno E; Garcia I; Corral MA; Fiaño C; Garcia-Muñoz H; Gomez-Sanz R Hepatogastroenterology; 1995 Jul; 42(3):212-21. PubMed ID: 7590568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]